(Q34874402)

5 August 2017

1 reference

title

Treatment of tick-borne diseases (English)

1 reference

5 August 2017

Brian J Donovan

1

1 reference

5 August 2017

David J Weber

series ordinal

2

1 reference

5 August 2017

John C Rublein

series ordinal

3

1 reference

5 August 2017

Ralph H Raasch

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Annals of Pharmacotherapy

5 August 2017

1 reference

5 August 2017

36

1 reference

5 August 2017

10

1 reference

5 August 2017

1590-1597

1 reference

Ticks and tickborne bacterial diseases in humans: an emerging infectious threat

5 August 2017

1 reference

Borrelia burgdorferi sp. nov.: Etiologic Agent of Lyme Disease

21 January 2018

1 reference

Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities

21 January 2018

1 reference

Role of Serology in the Diagnosis of Lyme Disease

21 January 2018

1 reference

Laboratory evaluation in the diagnosis of Lyme disease

21 January 2018

1 reference

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

21 January 2018

1 reference

A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium

21 January 2018

1 reference

Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice

21 January 2018

1 reference

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine

21 January 2018

1 reference

Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America

21 January 2018

1 reference

Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite

21 January 2018

1 reference

The early clinical manifestations of Lyme disease

21 January 2018

1 reference

Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis

21 January 2018

1 reference

Comparison of Cefuroxime Axetil and Doxycycline in the Treatment of Early Lyme Disease

21 January 2018

1 reference

Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis.

21 January 2018

1 reference

Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans

21 January 2018

1 reference

Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial

21 January 2018

1 reference

Comparison of azithromycin and doxycycline in the treatment of erythema migrans

21 January 2018

1 reference

Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis.

21 January 2018

1 reference

Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study

21 January 2018

1 reference

Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children--a prospective study

21 January 2018

1 reference

Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis

21 January 2018

1 reference

Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis

21 January 2018

1 reference

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

21 January 2018

1 reference

Rocky mountain spotted fever

21 January 2018

1 reference

Susceptibility of Rickettsia conorii and R. rickettsii to pefloxacin, in vitro and in ovo.

21 January 2018

1 reference

In vitro evaluation of josamycin, spiramycin, and erythromycin against Rickettsia rickettsii and R. conorii

21 January 2018

1 reference

In vitro susceptibilities of Rickettsia rickettsii and Rickettsia conorii to roxithromycin and pristinamycin

21 January 2018

1 reference

In vitro susceptibilities of Coxiella burnetii, Rickettsia rickettsii, and Rickettsia conorii to the fluoroquinolone sparfloxacin

21 January 2018

1 reference

Efficacy of chloramphenicol, enrofloxacin, and tetracycline for treatment of experimental Rocky Mountain spotted fever in dogs

21 January 2018

1 reference

Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin

21 January 2018

1 reference

In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin

21 January 2018

1 reference

Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, 'Israeli spotted fever group rickettsia' and Coxiella burnetii

21 January 2018

1 reference

In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, an

21 January 2018

1 reference

Human infection with Ehrlichia canis, a leukocytic rickettsia

21 January 2018

1 reference

Human granulocytic ehrlichiosis

21 January 2018

1 reference

In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis

21 January 2018

1 reference

The Spirochetal Etiology of Lyme Disease

21 January 2018

1 reference

Spirochetes Isolated from the Blood of Two Patients with Lyme Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1C089

1 reference

5 August 2017

1 reference